title: Long term persistence of thyrotropin receptor antibodies in wild-type and transgenic mice in a Graves' disease model.
abstract: Background:  Graves'-like disease, reflected by TSHR antibodies and hyperthyroidism in some mouse strains, can be induced by immunization with adenovirus expressing DNA for the human thyrotropin receptor (TSHR) or it's A-subunit.  The conventional approach involves two or three adenovirus injections at three-weekly intervals and euthanasia 10 weeks after the first injection.  In order to investigate TSHR antibody persistence in mice with differing degrees of self-tolerance to the TSHR A-subunit, we studied the effect of delaying euthanasia until 20 weeks after the initial immunization.  Methods: Wild-type mice and transgenic mice expressing low intrathyroidal levels of the human TSHR A-subunit were immunized with A-subunit-adenovirus on two occasions; a second group of mice was immunized on three occasions.  Sera obtained 4, 10 and 20 weeks (euthanasia) after the initial immunization were tested for TSH binding inhibition (TBI), antibody binding to TSHR A-subunit protein-coated ELISA plates and thyroid stimulating antibody activity (TSAb; cAMP generation). Serum thyroxine and thyroid histology were studied at euthanasia.      Results: The majority of wild-type mice retained high TSHR antibody levels measured by TBI or ELISA at euthanasia but only about 50% were TSAb positive. Low expressor transgenics exhibited self-tolerance, with fewer mice positive by TBI or ELISA and antibody levels were lower than in wild-type littermates.  In wild-type mice, antibody persistence was similar after two or three immunizations; for transgenics, only mice immunized three times had detectable TSAb at 20 weeks. Unlike our previous observations of hyperthyroidism in wild-type mice examined 4 or 10 weeks after immunization, all mice were euthyroid at 20 weeks.      Conclusions: Our findings for induced TSHR antibodies in mice, similar to data for human thyroid autoantibodies, indicate that the parameters that contribute to the concentration of the antibody and thereby play a critical role in long term persistence of TSHR antibodies are the degree of self-tolerance to the TSHR and chronic stimulation.
authors.affiliation: Cedars-Sinai Research Institute & UCLA, Endocrinology, 8700 Beverly Blvd, B-131, Los Angeles, California, United States, 90048, (1) 310 423 7680, 310 423 0221;  mclachlans@cshs.org.
authors.forename: Sandra M
authors.initials: SM
authors.lastname: McLachlan
authors.forename: Holly
authors.initials: H
authors.lastname: Aliesky
authors.forename: Chun-Rong
authors.initials: CR
authors.lastname: Chen
authors.forename: Basil
authors.initials: B
authors.lastname: Rapoport